Emcure Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 181.15 | 180.85 | 180.85 | 180.85 | 180.85 |
Reserves | 1,753.95 | 1,661.02 | 1,531.68 | 2,120.92 | 1,733.70 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 1,935.10 | 1,841.87 | 1,712.53 | 2,301.77 | 1,914.55 |
Secured Loans | 1,415.71 | 1,668.79 | 1,578.82 | 1,299.52 | 1,190.72 |
Unsecured Loans | 179.74 | 103.84 | 0.00 | 303.86 | 52.59 |
Total Debt | 1,595.45 | 1,772.63 | 1,578.82 | 1,603.38 | 1,243.31 |
Other Liabilities | 62.35 | 52.04 | 134.49 | 98.26 | 43.91 |
Total Liabilities | 3,592.90 | 3,666.54 | 3,425.84 | 4,003.41 | 3,201.77 |
APPLICATION OF FUNDS : | |||||
Gross Block | 2,926.52 | 2,472.14 | 2,031.30 | 1,882.69 | 1,761.83 |
Less: Accumulated Depreciation | 1,208.28 | 1,039.44 | 879.82 | 735.44 | 595.77 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 1,718.24 | 1,432.70 | 1,151.48 | 1,147.25 | 1,166.06 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 106.40 | 253.10 | 239.25 | 192.09 | 326.06 |
Investments | 684.00 | 690.02 | 563.36 | 863.73 | 407.71 |
Current Assets, Loans & Advances | |||||
Inventories | 770.27 | 709.93 | 730.44 | 621.77 | 443.66 |
Sundry Debtors | 1,103.29 | 1,054.50 | 1,009.09 | 999.43 | 1,138.29 |
Cash and Bank Balance | 32.12 | 141.02 | 47.88 | 260.73 | 39.22 |
Loans and Advances | 217.75 | 234.06 | 354.21 | 333.53 | 186.39 |
Total Current Assets | 2,123.43 | 2,139.50 | 2,141.63 | 2,215.46 | 1,807.56 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 1,090.56 | 879.42 | 808.62 | 778.33 | 568.23 |
Provisions | 44.54 | 39.64 | 59.02 | 53.43 | 69.09 |
Total CL & Provisions | 1,135.09 | 919.06 | 867.64 | 831.76 | 637.32 |
Net Current Assets | 988.34 | 1,220.44 | 1,273.98 | 1,383.69 | 1,170.24 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 71.54 | 46.39 | 0.00 | 37.33 | 31.75 |
Deferred Tax Liability | 100.48 | 76.63 | 29.70 | 65.34 | 63.87 |
Net Deferred Tax | -28.94 | -30.24 | -29.70 | -28.01 | -32.12 |
Other Assets | 124.85 | 100.52 | 227.47 | 444.67 | 163.81 |
Total Assets | 3,592.89 | 3,666.54 | 3,425.84 | 4,003.42 | 3,201.76 |
Contingent Liabilities | 162.14 | 2.08 | 4.34 | 0.00 | 0.00 |